Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary of Stock Option Activity (Details)

v3.24.3
Stock-Based Compensation - Summary of Stock Option Activity (Details) - 2014 Amended and Restated Plan - Share-Based Payment Arrangement, Option - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Sep. 30, 2024
Dec. 31, 2023
Number of Shares      
Balance at the beginning (in shares) 498,298 498,298  
Granted (in shares)   1,259,600  
Cancelled (in shares)   (10,048)  
Forfeited (in shares)   (108,496)  
Balance at the ending (in shares)   1,639,354  
Exercisable (in shares)   519,839  
Weighted Average Exercise Price      
Balance at the beginning (in dollars per share) $ 8.96 $ 8.96  
Granted (in dollars per share)   11.35  
Cancelled (in dollars per share)   126.76  
Forfeited (in dollars per share)   9.22  
Balance at the ending (in dollars per share)   10.05  
Exercisable (in dollars per share)   $ 11.36  
Weighted Average Remaining Contractual Term (Years)      
Weighted Average Remaining Contractual Term (Years) 7 years 2 months 26 days 8 years 3 months 29 days  
Weighted Average Remaining Contractual Term, Exercisable   5 years 9 months 3 days  
Aggregate Intrinsic Value   $ 158,794 $ 20,441
Aggregate Intrinsic Value, Exercisable   $ 71,783